dr. ferris on pembrolizumab and nivolumab in head and neck cancer
Published 7 years ago • 207 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
1:34
dr. ferris discusses nivolumab in head and neck cancer
-
1:36
dr. ferris on potential of nivolumab in head and neck cancer
-
1:17
dr. ferris on fda approval of nivolumab in patients with head and neck cancer
-
1:44
dr. ferris on impact of fda approval of pembrolizumab in patients with head and neck cancer
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
6:51
pembrolizumab and nivolumab in recurrent hnscc
-
1:20
dr. ferris on combining immunotherapy and radiation therapy in head and neck cancer
-
2:25
dr. ferris on checkmate-141 trial in head and neck cancer
-
0:40
dr. vokes on selecting nivolumab or pembrolizumab for head and neck cancer treatment
-
1:15
dr. ferris on significance of checkmate-141 trial for head and neck cancer
-
1:09
dr. ferris on immunotherapy in locally advanced head and neck cancer
-
0:54
dr. robert ferris on a phase iii study regarding nivolumab in head and neck cancer
-
2:07
study results for nivolumab and pembrolizumab in head and neck cancer
-
2:13
nivolumab in hnscc
-
0:54
dr. ferris on a trial testing adu-s100/miw815/pembrolizumab in head and neck cancer
-
0:53
dr. ferris on combining sting agonists with checkpoint inhibitors in head and neck cancer
-
2:01
dr. ferris on the updated data from checkmate-141 in head and neck cancer
-
0:40
dr. joshua m. bauml on pembrolizumab versus chemo in head and neck cancers
-
0:55
dr. cohen on immunotherapy in head and neck squamous cell carcinoma